The Director of Bioanalytical Services is a hands-on CMC analytical leader responsible for Fulgent Pharma’s analytical development and quality control capabilities, supporting the oncology pipeline from early development through clinical stages and eventual commercialization. The role combines ownership of the analytical control strategy with direct laboratory execution, vendor oversight, and cross-functional leadership in a small, fast-moving biotech environment. The Director establishes analytical methods, systems, and workflows, ensuring phase-appropriate rigor, regulatory compliance, and efficient use of internal and external resources. Bench work is expected to account for 10–30% of the role, depending on phase. The Director owns analytical strategy for drug products and novel excipients; develops, qualifies, validates, and troubleshoots analytical methods; designs forced-degradation, stability-indicating method development, and characterization studies; and establishes phase-appropriate specifications. The role also oversees lab operations and instrumentation, leads CRO/CMO analytical work, supports regulatory filings and agency interactions, and owns stability programs, reference standards, quality investigations, and data integrity practices. The position builds and mentors a small analytical team, provides technical guidance and training, and promotes scientific rigor, urgency, and accountability. It also ensures safe analytical laboratory operations and supports safety committee activities and continuous improvement of safety practices.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree